Compare BioNano Genomics Inc (BNGO) vs Halliburton Company (HAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Halliburton Company — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while Halliburton Company trades at $33.67 (market cap $28.16B). The key difference: Halliburton Company is far larger — about 2061.5× BioNano Genomics Inc's market cap, and Halliburton Company pays a 2.01% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | HAL | |
|---|---|---|
Market Cap | $13.66M | $28.16B |
Sector | Health | Energy |
52-Week High | $4.92 | $42.98 |
52-Week Low | $1.06 | $20.97 |
Enterprise Value | $16.26M | $34.31B |
Dividend Yield | — | 2.01% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Halliburton Company
Halliburton is one of the three largest oilfield service firms in the world, offering superior expertise in a number of business lines, including completion fluids, wireline services, cementing, and countless others. It's the number one pressure pumper in North America, and has been a leading innovator in hydraulic fracturing over the last two decades.
Read more on HAL →
